Evidence map›Paper›PMID 33970329›Full record

ArticleArchivum immunologiae et therapiae experimentalis2021

Donor Recipient Chimeric Cells Induce Chimerism and Extend Survival of Vascularized Composite Allografts.

Joanna Cwykiel, Arkadiusz Jundzill, Aleksandra Klimczak, Maria Madajka-Niemeyer, Maria Siemionow

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archivum immunologiae et therapiae experimentalis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Tolerance Induction in Vascularized Composite Allotransplantation-A Brief Review of Preclinical Models.Transplant international : official journal of the European Society for Organ Transplantation · 2023
    Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Joanna CwykielDepartment of Orthopaedics, University of Illinois At Chicago, Molecular Biology Research Building, 900 S. Ashland Ave. Room# 3356, Chicago, IL, 60607, USA.
Arkadiusz JundzillDepartment of Plastic Surgery, Cleveland Clinic, Cleveland, OH, USA.
Aleksandra KlimczakDepartment of Plastic Surgery, Cleveland Clinic, Cleveland, OH, USA.
Maria Madajka-NiemeyerDepartment of Plastic Surgery, Cleveland Clinic, Cleveland, OH, USA.
Maria SiemionowDepartment of Orthopaedics, University of Illinois At Chicago, Molecular Biology Research Building, 900 S. Ashland Ave. Room# 3356, Chicago, IL, 60607, USA. siemiom@uic.edu.ORCID http://orcid.org/0000-0001-6372-6122
Cleveland Clinic · USPoznan University of Medical Sciences · PL

Funding

U.S. Department of Defense W81XWH-08-2-0034
6 · The paper itself

Abstract

This study evaluated the efficacy of donor recipient chimeric cell (DRCC) therapy created by fusion of donor and recipient derived bone marrow cells (BMC) in chimerism and tolerance induction in a rat vascularized composite allograft (VCA) model. Twenty-four VCA (groin flaps) from MHC-mismatched ACI (RT1

Indexed as

AnimalsBone Marrow CellsBone Marrow TransplantationComposite Tissue AllograftsDisease Models, AnimalGraft RejectionGraft SurvivalHumansMaleRatsTissue DonorsTransplantation ChimeraTransplant RecipientsCell fusionDonor recipient chimeric cellsGroin flapVascularized composite allotransplantation

Identifiers

PMID33970329
PMCPMC8110509
OpenAlexW3163687645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.